Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/&#x03B2;-catenin signaling

Yun Peng; Jun Cao; Xiao-Yi Yao; Jian-Xin Wang; Mei-Zuo Zhong; Ping-Ping Gan; Jian-Huang Li

doi:10.18632/oncotarget.28315

Oncotarget

On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed.
Learn more.

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling

PDF | How to cite

Oncotarget. 2022; 13:1301-1301. https://doi.org/10.18632/oncotarget.28315

Metrics: PDF 560 views | ?

Yun Peng¹, Jun Cao², Xiao-Yi Yao³, Jian-Xin Wang⁴, Mei-Zuo Zhong³, Ping-Ping Gan³ and Jian-Huang Li³

¹International Medical Center, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
²Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410008, P.R. China
³Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
⁴School of Information Science and Engineering, Central South University, Changsha 410008, P.R. China

Published: December 06, 2022

Copyright: © 2022 Peng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget requested the original data for this paper to address concerns regarding image duplication. The authors were unable to retrieve the data. As a result, all authors have agreed to the retraction of this paper from Oncotarget. The University was notified about the issues with the paper.

Original article: Oncotarget. 2017; 8:52960–52974. DOI: https://doi.org/10.18632/oncotarget.17674

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28315

Announcements

Publication Alerts

Retraction:

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling